Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Prescribers of Pegintron (US)(?)

Council Members in this Study Group: 23

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Miguel Rodriguez, MD
Hepatologist and Gastroenterologist
Miami Gastroenterology Consultants PA

Miguel Rodriguez, MD, is a Hepatologist & Gastroenterologist, Managing Partner of Miami Gastroenterology Consultants, PA., a single specialty group in Miami, Florida. He is former Assistant Professor of Medicine of the University of Miami School of Medicine and Center for Liver Diseases and Division...

Averell Sherker, MD
Associate Professor of Clinical Medicine
Georgetown University - CC

Averell Sherker, MD, FRCP, is Director of the Center for Liver Diseases at Washington Hospital Center in Washington, DC. He is also Associate Professor of Clinical Medicine at Georgetown University. Previously, Dr. Sherker was Director of Hepatology Research at the McGill University in Canada, where...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Unfortuantely, the IDEAL study is less than ideal in comparing two different pegylated interferons (Peg-Intron vs Pegasys) in the treatment of HCV.  This is primarily due to differences in ribarivin dose and reduction schedules between these treatment groups.  We have come to learn that the...

October 31, 2007
Boceprevir

I am not impressed. I am wandering why the responces were so low in non-respoders. will be happy to discuss

Analysis of: Survey: Did the FDA Jump the Gun on PPIs? | www.medpagetoday.com

- The FDA is under significant scrutiny and pressure following slow dissemination of new data regarding the safety of COX-2 inhibitors (ie-Vioxx) and the "-glitazones" (Avandia/Actos) - PPIs are among the most widely used medications wordwide (mostly prescribed) with tens on millions of users annually,...

Infection with Hepatitis A and/or Hepatitis B can be associated with significant liver injury, particularly in individuals with pre-existing liver disease such as Hepatitis C, alcohol associated liver disease. However, both Hepatitis A and B can be prevented via vaccination. Previously, individuals...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Free-standing Surgery Center
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Partner
  • Physician - Fellow
  • Physician - Division Head
  • Physician - Department Chair
  • Medical Director

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880